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ABSTRACT A ZnO@ZIF-8 powder on a gram scale was prepared via treatment of ZIF-8 with 
silver nitrate to induce spontaneous formation of ZnO nanorods on the surface of the ZIF-8 
crystals. The crystal structure, phase purity and physicochemical characteristics of ZnO@ZIF-8 
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were determined by X-ray diffraction, high resolution electron microscopy, energy dispersive 
spectroscopy and nitrogen adsorption. The antimicrobial potential of ZnO@ZIF-8 for reduction 
of microorganisms often implicated with catheter-associated urinary tract infections (CAUTIs) 
was studied in detail using four target pathogens, Escherichia coli, Klebsiella pneumoniae, 
Proteus mirabilis and Staphylococcus aureus. The ability of the compound to kill all four 
microorganisms in suspension was established and a minimum bactericidal concentration of 0.25 
mg mL-1 was determined for each microorganism. ZnO@ZIF-8 compound was found to be no 
more toxic to Galleria mellonella than distilled water, which was assessed by injection of 
Galleria with 10 µL of ZnO@ZIF-8 of concentrations of up to 2 mg mL-1. ZnO@ZIF-8 
suspensions (2 mg mL-1 concentration) were able to reduce well-established biofilms of all four 
oraganisms containing between 107 and 109 CFU mL-1 to below limit of detection (BLD) over a 
24-h period. Silicone-embedded ZnO@ZIF-8 (2wt.% or 4 wt.% ZnO@ZIF-8 loading) also 
demonstrated antimicrobial properties with all four microorganisms being eliminated from the 
surface within 24 h. The ZnO@ZIF-8 high potency and rapid anti-biofilm activity against all 
four test organisms coupled with its non-toxicity offers a new avenue for control of microbial 
colonization of catheters, which would ultimately result in reduction of CAUTIs. 
1. INTRODUCTION 
Urinary tract infections (UTIs) are the fourth most common healthcare-associated infection in 
US hospitals,1 with upwards of 70% of UTIs being linked to catheterization of a patient.2 
Catheters pose a significant risk as a microbial reservoir due to the often prolonged use and flow 
of nutrient-rich liquids combined with the ability of microorganisms to adhere to the surface and 
grow complex communities (biofilm), leading to colonization of the catheter. Biofilms linked 
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with catheter-associated urinary tract infections (CAUTIs) are able to resist antimicrobial 
activity, and often cause catheter blockages, with the risk of bacteremia increasing by three to 
seven percent everyday a patient is catheterized.3 CAUTIs can be caused by a number of 
potentially pathogenic microorganisms, with Escherichia coli, Klebsiella pneumoniae, Proteus 
mirabilis and Staphylococcus aureus being commonly isolated from colonized catheters.4 These 
bacteria are also included on the WHO Priority Pathogens list relating to the most clinically 
significant antimicrobial resistant microorganisms.5 
Although common strategies to control microbial colonization of catheters such as aseptic 
handling and reduced catheterization time are beneficial, alterations to the catheter material may 
also provide benefits. Currently, the majority of catheters are made of plastics or latex.6 
However, attempts have been made to modify these materials to include biocides and other 
antimicrobial compounds such as hydrogels, lecithin, silver-coatings and impregnation with 
compounds such as antibiotics, essential oils or nitric oxide.6-12 Various meta-analyses of studies 
into the efficacy of antimicrobial catheters have shown their potential for reducing infections.13,14 
Metal-organic frameworks (MOFs) are a relatively new class of inorganic-organic hybrid 
materials constructed via covalent bonding of metal ions/clusters with the polydentate bridging 
ligands.15 Due to their structural diversity, excellent permanent porosity, tunable pore size and 
high chemical functionality, MOFs have shown their potential use for a vast range of 
applications ranging from gas storage,16,17 separation,18 catalysis,19 and chemical sensing20 to 
advanced biomedicine,21,22 drug delivery and bioimaging.23 Combining the tailorability of the 
MOF with the versatile functionality of metal oxide nanoparticles (e.g. TiO2, ZnO, and Ag2O) 
with novel physicochemical properties are particularly attractive for the fundamental search of 
emerging potential applications in the field of advanced nanotechnology, such as solar cell, 
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selective sensing, separation and photocatalysis.24-29 For example, ZnO@ZIF-8 core-shell 
nanostructures have shown selective photoelectrochemical response to H2O2, excluding the 
bulkier interfering chemicals such as ascorbic acid present in the buffer solution.30 ZnO@ZIF-8 
core-shell heterostructure has also been reported as promising photocatalyst for selective 
reduction of Cr(VI) between Cr(VI) and methylene blue.31 In these systems, the ZnO nanorods 
not only act as the template but also provide Zn2+ ions for the formation of ZIF-8 in 2-
methylimidazolate solution via solvothermal treatment.30,31 
Alternatively, we have successfully demonstrated a spontaneous phase segregation of ZIF-8 
into ZnO nanorods upon exposure of ZIF-8 nanocrystals to an aqueous solution of silver nitrate 
at room temperature (Scheme 1).32 ZnO@ZIF-8 composite is photocatalytically active for the 
photodegradation of methylene blue.32 ZnO nanorod having a band-gap energy of 3.16 eV has 
attracted much attention due to its unique optical, electrical and chemical properties, making it an 
ideal nanomaterial for optoelectronics, piezoelectric generators and biotechnology.32,33 The 
antibacterial behavior of ZnO nanoparticles has been documented in the literature.34,35 Inspired 
by the long-term broad spectrum antibacterial activity of ZnO nanoparticles, the fabrication of 
multifunctional ZnO@ZIF-8 nanocomposite could be useful for biomedical applications. 
Moreover, thanks to the inorganic-organic hybrid property of MOF, it allows facile processing of 
MOF-based composite materials into application-specific configurations, such as mixed matrix 
membranes due to the excellent chemical compatibility between the MOF filler and the polymer 
phase.36,37 In this study, we show laboratory upscaling synthesis of a gram-scale ZnO@ZIF-8 
nanocomposite and its potential application as biofilm inhibitor to prevent colonization by 
common pathogens associated with urinary tract infection. More importantly, we also 
demonstrate the incorporation of ZnO@ZIF-8 nanocomposite into silicone elastomers to form 
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self-supporting composite material with high antimicrobial property against catheter-associated 
urinary tract infection pathogens. 
Scheme 1. Schematic representation the spontaneous local transformation of pre-synthesized 
ZIF-8 into nanocomposite of ZIF-8 with embedded ZnO nanorods induced by silver nitrate 
solution at room temperature. 
 
2. EXPERIMENTAL SECTION 
2.1. Gram-scale synthesis of ZnO@ZIF-8. 11.75 g of Zn(NO3)2⋅6 H2O (ACROS Organic) 
was dissolved in 200 mL of dimethylformamide (DMF, ACROS Organic) and 25.92 g of 2-
methylimidazole (ACROS Organic) was dissolved in 200 mL of DMF. The 2-methylimidazole 
solution was added to the zinc nitrate solution under vigorous stirring for 5 min. Spontaneous 
precipitation was observed after mixing. The mixture was poured into a 2 L SCHOTT bottle 
(DURAN) and heated at 140 °C for 4 h in an oven. The product was recovered and washed with 
DMF through repeated centrifugation and redispersion in an ultrasonic bath. Solvent exchange 
was performed with absolute ethanol (200 mL) (Fisher Chemical) three times over three days. 
The product was dried in an oven at 80 °C. 1.0 g of ZIF-8 powder was dispersed in an aluminium 
foil-covered glass bottle containing 35 mL of 53.7 mM silver nitrate (ACROS Organic) Milli-Q 
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ultrapure water:ethanol (v/v= 1:6) solution and stirred overnight. The solid was washed with 
absolute ethanol (200 mL) two times and dried at room temperature. 
2.2 Characterization of ZnO@ZIF-8. ZnO@ZIF-8 was characterized by a powder X-ray 
diffractometer (XRD, STOE StadiP diffractometer in high-throughput transmission mode 
employing Cu Kα1 radiation), N2 adsorption instrument (Micromeritics Tristar 3000); sample 
was activated at 150 °C under nitrogen flow overnight prior to measurement, and a Nova Nano 
scanning electron microscope NanoSEM450 (FEI, Eindhoven). Bright field TEM (BF-TEM), 
high resolution TEM (HR-TEM) and energy-dispersive X-ray spectroscopy (EDX) were 
performed with a probe-corrected transmission electron microscope (ARM200F cold-FEG, 
JEOL) operated at acceleration voltage of 200 kV. TEM samples were prepared by dispersing 
the powder in 2-propanol and placing a few drops of the solution onto the copper TEM grids 
covered with lacey carbon film (Pacific Grid Tech, USA). 
2.3. Maintenance and standardization of microorganisms. Escherichia coli (E. coli, NCTC 
9001), Klebsiella pneumoniae (K. pneumoniae, NCTC 13368), and Staphylococcus aureus (S. 
aureus, NCTC 6571) were maintained on Luria-Bertani (LB) agar (BD, Sparks, MD), and 
Proteus mirabilis (P. mirabilis, NCTC 60) was maintained on cystine lactose electrolyte 
deficient (CLED) agar (Oxoid, Basingstoke), at 4 °C. For the ‘minimum bactericidal 
concentration’ assay, 2-4 colonies of each culture were inoculated into 100 mL of Mueller-
Hinton (MH) broth independently and grown 22 ± 1 h at 37 °C with agitation (180 rpm). Cells 
were harvested by centrifugation (3600 rpm, 10 min) and resuspended in MH broth to an optical 
density of 0.025 at 600 nm (Jenway 6305 Spectrophotometer, UK) resulting in a suspension 
concentration of 3.11± 0.3x106 CFU mL-1. For ‘assessment of antimicrobial efficacy of 
ZnO@ZIF-8-containing silicone elastomers’ and ‘efficacy of ZnO@ZIF-8 as an antibiofilm 
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agent’ assays, 2-4 colonies were inoculated into 100 mL of LB broth and grown at 22 ± 1 h at 37 
°C with agitation (180 rpm). Cells were harvested by centrifugation (3600 rpm, 10 min), washed 
once in 0.85% NaCl (Oxoid), and resuspended in 0.85% NaCl to optical density 1.0 at 540 nm 
resulting in a suspension concentration of 1.87 ± 0.51x108 CFU mL-1. 
2.4. Minimum bactericidal concentration (MBC) assay. MBC assays are used as a screen to 
determine the minimum amount of an antimicrobial compound that is sufficient to reduce 
bacterial survival in liquid culture. For the purpose of this study, the MBC was considered the be 
the smallest concentration of a compound that was capable of killing all cells (i.e. zero cells 
recovered on agar). The following suspensions were tested: ZIF-8 powder suspended in sterile 
distilled water to a concentration of 4 mg mL-1, ZnO (20wt.% nanoparticle suspension in H2O, 
particle size < 100 nm, Sigma-Aldrich) suspended in sterile distilled water to a concentration of 6 
mg mL-1 and ZnO@ZIF-8 powder suspended in sterile distilled water to a concentration of 4 mg 
mL-1. A doubling dilution was then performed in a 96-well plate down to a concentration of 
0.0625 mg mL-1 for ZIF-8 and ZnO@ZIF-8 and 0.05 mg mL-1 for ZnO, leaving a 100 L volume 
of each dilution in its corresponding well. 100 L of standardized E. coli in MH broth (as 
described above) was put into each well and incubated and covered with lid, at 37 °C for 18 h. 
100 L of culture plus 100 L of sterile distilled water was used as a positive control and 100 L 
of suspended ZnO@ZIF-8 plus 100 L of sterile distilled water was used as a negative control. 
20 L samples were taken from each well after mixing of each well with the pipette, pipetted 
onto LB agar, and incubated for 24 h at 37 °C. The lowest concentration at which growth was 
prevented was recorded as the MBC. Three independent replicates were tested in each 
experiment and the experiment was repeated once for the three remaining bacterial strains. 
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2.5. Toxicity of ZnO@ZIF-8 using the model Galleria mellonella. G. mellonella, in the 
caterpillar larvae stage, are 2-2.5 cm long and cream in color. They can be used as a model for 
infection and toxicity.38 G. mellonella (Livefood UK Ltd, Somerset) were injected with 10 L of 
2 mg mL-1, 1 mg mL-1, 0.5 mg mL-1 and 0.25 mg ml-1 of ZnO@ZIF-8 powder suspended in 
sterile distilled water using a 22 gauge needle (Hamilton Company, Reno) and repeating 
dispenser syringe (Hamilton Company). Target injection site was the rear left proleg. Ten 
Galleria per experimental condition were used. Galleria were incubated at 37 °C for 96 h. 
Change from the standard creamy color to black and non-motile was indicative of death and 
assessed every 24 h. Each experiment was repeated once. 
2.6. Efficacy of ZnO@ZIF-8 as an antibiofilm agent. MBECTM biofilm assay plate are 
designed to establish a biofilm on one of ninety-six pegs, each of which sit within a well. Once a 
biofilm is established, the pegs can be transferred into another well containing an antimicrobial 
agent, with resulting antimicrobial action determined by counting colonies.39 In order to establish 
a biofilm, 200 L of a 1:100 dilution of bacteria in fresh LB broth was placed in the wells of a 
MBECTM biofilm assay plate (Innovotech, Edmonton). Lid with attached pegs was replaced and 
plates incubated for 48 h at 37 °C in an orbital shaker (110 rpm). LB broth from wells was 
replaced with fresh LB broth after 24 h. To assess the antimicrobial efficacy against the 
established biofilms, 200 L of ZnO@ZIF-8 suspended in sterile distilled water was placed in 
the wells of a fresh 96-well plate, at concentrations of 2 mg mL-1, 1 mg mL-1 and 0.5 mg mL-1, 
using sterile distilled water as a negative control. The MBECTM biofilm assay plate lid 
(containing the pegs with established biofilms) was then placed into the wells containing the 
ZnO@ZIF-8 suspension, and incubated for 24 h at 37 °C in an orbital shaker (110 rpm). 
Following incubation with the ZnO@ZIF-8 suspension, MBECTM assay lid with attached pegs 
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was removed and gently washed twice in sterile distilled water. 200 L of sterile distilled water 
was then placed in wells of a fresh 96-well plate, into which the MBECTM assay lid was placed, 
and cells were removed from pegs into the wells by placing the plate and lid in a sonicating 
water bath (Sonicor, Copiague, NY) for 20 min. The resultant bacterial suspension was then 
diluted 10-fold (100 L into 900 L of sterile physiological saline), to 10-7. 100 L of each 
dilution was pipetted in duplicate onto LB agar (CLED was used for P. mirabilis) and spread 
evenly across the agar surface. Plates were incubated for 18 h at 37 °C, after which the number 
of colonies was counted to calculate CFU mL-1. Time points sampled were 0, 3, 8, and 24 h. All 
microorganisms were tested over four biofilms (i.e. four pegs) per time point, the experiment as a 
whole was repeated once. 
2.7. Assessment of antimicrobial efficacy of ZnO@ZIF-8-containing silicone elastomers. 
Silicone elastomers (SE) were prepared from samples of M511 maxillofacial material 
(Technovent, UK), comprising of a mixture consisting of 29.106 g of Part A (Silicone polymer 
with Si-H groups) and 3.234 g of part B (vinyl functionalized dimethyl silicone polymer, plus Pt 
catalyst) according to the manufacturer’s instructions. The system components were mixed for 
60 s under vacuum using Multivac 4 (Degussa AG, Germany). After a resting time of 15 min, the 
uncured SE was spread into a 13 cm x 13 cm x 1 cm metal mold using a pallet knife. The mold 
was placed on a vibrating table for 10-15 min to bring the air bubbles to the surface and the 
bubbles were burst using a thin wire. The molding was cured at 100 °C for 1 h. After curing, the 
SE was removed from the steel mold, cut into 1x1 cm pieces and stored in a polythene bag. A 
melinex sheet was used in the mold to ease the recovery of the cured SE. ZnO@ZIF-8-
containing silicone elastomers were prepared similarly after adding either 2 or 4 wt.% 
ZnO@ZIF-8 to the uncured SE mixture. To assess their antimicrobial potential against the four 
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test organisms described above, pieces of SE were inoculated with 10 L of washed and 
standardized cell suspension, and a 1x1 cm piece of polyethylene (SLS, Nottingham) was placed 
gently on top. Coupons where placed in a petri dish inside a humid container and incubated at 37 
°C. At the appropriate sample time, the SE coupon with PE sheet was dropped into 10 mL of 
neutralizing buffer (15 g Tween80 (Sigma- Aldrich, Dorset) and 30 g Soya Lecithin (Optima 
Healthcare Lecithin, Holland and Barrett, UK) dissolved in 1 L of distilled water,40 vortex-mixed 
for 30 s to remove the polyethylene from SE and remove any cells from the surface into the 
liquid. The neutralizing buffer was included to halt any antibacterial action of ZnO@ZIF-8 at the 
appropriate time point. The resultant bacterial suspension was then diluted 10-fold (1 mL into 9 
mL of sterile physiological saline), seven times, to a concentration of 10-7 of the original 
suspension. 100 L of each dilution was pipetted out in duplicate onto LB agar (CLED was used 
for P. mirabilis) and spread evenly across the agar surface. Plates were incubated for 18 h at 37 
°C, after which the number of colonies was counted to calculate CFU mL-1. Time points sampled 
were 0, 3, 8, and 24 h. All silicone samples were duplicated and the experiment was repeated as a 
whole once. 
2.8. Growth of biofilm for SEM studies 
SE were prepared, as described in 2.7, and cut into 1x1cm pieces. The four target pathogens 
were grown as described in method section 2.3, and resuspended in LB broth to an optical 
density of 1.0 at 540 nm. SE pieces were placed in a 12-well plate and immersed in one of the 
test pathogens and incubated, stationary, at 37 °C for 48 h. SE were then removed, washed 
gently with sterile distilled water and fixed in 4% glutaraldehyde (sample fully submerged in 25 
mL) at 4 °C for 12 h. Samples were then removed from fixative and an ethanol gradient was 
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completed as follows: 30% EtOH for 10 min, 50% EtOH for 10 min, 70% EtOH for 10 min, 
90% EtOH for 10 min and 100% EtOH for 10 min, all at room temperature. SE were mouted to 
SEM stubs and coated with gold priot to SEM analysis. The SEM analysis was performed with a 
Carl Zeiss Ltd 40VP Supra scanning electron microscope. 
3. RESULTS AND DISCUSSION 
3.1. Characterization of ZnO@ZIF-8. The crystal structure and the phase purity of 
ZnO@ZIF-8 were confirmed by XRD. The XRD pattern of ZnO@ZIF-8 (Fig. 1b) reveals 
additional characteristic diffraction peaks of 31.76, 36.17, 45.71 and 56.54 at 2 values, which 
are corresponding to the crystallographic planes of (010), (011), (012) and (110), assigned to 
ZnO, in additional to the XRD fingerprint which is corresponding to the sodalite zeolitic 
topology (Fig. 1a).32,41 No other diffraction peak is observed which confirms the phase purity of 
ZnO@ZIF-8 composite. It should be mentioned that in our firstly synthesized ZnO@ZIF-8 
sample, the composite contained a small amount of impurity.32 In this study, we have 
successfully obtained a phase-pure ZnO@ZIF-8 sample through repeated washing with absolute 
ethanol. The permanent porosity of ZnO@ZIF-8 sample was confirmed by nitrogen 
physisorption analysis as shown in Fig. 1c. The ZnO@ZIF-8 composite has a respective specific 
BET surface area and a micropore volume of 1112 m2 g−1 and 0.50 cm3 g−1. The presence of the 
ZnO nanoparticles is confirmed by high-resolution SEM (HRSEM) imaging. Fig. 1d shows that 
the ZIF-8 crystals have a clear enrichment of ZnO near to the surface as indicated by arrows. The 
observed contrast between the ZnO nanorods and ZIF-8 crystals in the HRSEM image is known 
due to the mass thickness sensitivity.42,43 Fig. 1d allocates clearly the ZIF-8 crystals with regions 
of surface enrichment, showing the presence of 80-90 nm-sized ZnO particles, homogeneously 
distributed on the surface of ZIF-8 crystals. 
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Figure 1. (a) The chemical structure of ZIF-8. The blue tetrahedra show the zinc-nitrogen bonds. 
The orange sphere represents the open-pore structure of ZIF-8. Characterization of ZnO@ZIF-8 
by (b) XRD, (c) nitrogen physisorption and (d) HRSEM. The arrows in (d) show the enrichment 
of ZnO nanorods. 
The structural morphology and elemental composition of ZnO@ZIF-8 were characterized in 
detail by TEM and EDX. Fig. 2 (a-c) shows the BF-TEM images of the synthesized ZnO@ZIF-8 
nanocomposite at different magnifications. The small ZnO nanorods (visible as elongated 
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structures with darker contrast) are evenly distributed on the surface of the ZIF-8 as is visible in 
Fig. 2a. HR-TEM image is used to further confirm the presence of ZnO nanorods in ZnO@ZIF-8 
nanocomposite. The HR-TEM image (Figure 2d) shows the lattice fringes of ZnO and confirms 
the crystallinity of the nanorods. Fig. 2e shows the corresponding fast Fourier transformation 
(FFT) analysis. The lattice spacing values are calculated to be 0.52, 0.25 and 0.28 nm in 
agreement with the spacing of the (001), (101) and (100) crystalline plane of the ZnO phase, 
respectively. Accordingly, the zone axis is parallel with the [010] axis of ZnO. The FFT pattern 
is consistent with the XRD results. The EDX spectrum of ZnO@ZIF-8 composite shown in Fig. 
2f asserts the presence of carbon (C), nitrogen (N), oxygen (O), zinc (Zn) and copper (Cu) 
elements. The presence of C, N and Zn is in agreement with the chemical composition of ZIF-8. 
The Cu signal is due to the Cu TEM grid.The absence of any other elements in the EDX 
spectrum suggests the phase purity of the synthesized ZnO@ZIF-8. 
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Figure 2. (a, b and c) BF-TEM image of the ZnO@ZIF-8 sample at different magnifications, (c) 
is the BFTEM image of indicated area in (b) at higher magnification; (d) HR-TEM of the ZnO 
nanorods and (e) corresponding fast FFT analysis of ZnO nanorods, which confirms a lattice 
spacing of 0.28 nm for (100) planes and 0.52 nm for (001) planes. These d-spacings are in 
agreement with the ZnO structure. The zone-axis was found to be [010] direction. (f) EDX 
spectrum taken from the ZnO@ZIF-8 composite. 
3.2.  MBC assay and toxicity assay using the model Galleria mellonella. The lowest  
concentration that ZnO was able to kill each of the test organisms (MBC) was 0.8 mg mL-1, 
whilst the ZIF-8 compound exhibited no bactericidal affect. The MBC of ZnO@ZIF-8 was 0.25 
mg mL-1for each of the four test organisms. Lower concentrations were unable to kill the test 
organisms. It has also been reported that the ZnO-loaded polydimethylsiloxane was not active 
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against E. coli and S. aureus under dark conditions.44 This data demonstrates that the ZnO@ZIF-
8 compound exhibits greater antimicrobial action against the four test organisms than either ZnO 
or ZIF-8 alone. Moreover, due to hybrid inorganic-organic nature of ZIF-8 compound, the 
fixation of ZnO nanorods into the matrix of ZIF-8 helps to enhance the dispersibility of inorganic 
ZnO nanoparticles, which makes them benefitial as compatible additives to polymers compared 
to ZnO (Fig. 3). The excellent biocompatibility between the MOF-nanocomposite and polymer is 
of significant importance for future fabricating of implantable medical devices such as 
intravascular catheters, urinary catheters and others.45 
 
 
Figure 3. Digital images of samples dispersed in chloroform: (left) ZnO, (middle) ZIF-8 and 
(right) ZnO@ZIF-8. The photograph was originally taken by LT.  
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Figure 4. a) Living Galleria mellonella. b) Top larvae is alive (cream in colour) and the bottom 
larvae is dead (black in colour). The photograph was originally taken by JR. Images presented 
here are for demonstration purposes and do not represent specific data.  
Galleria mellonella, a wax-worm moth used as a model organism for toxicity testing. Larvae 
are characteristically cream in colour if alive and turn black when they die (Fig. 4). Fig. 5 shows 
the percentage of Galleria mellonella that were alive following injection with 10 μL of either 0.5 
mg mL-1 of ZnO@ZIF-8, 1 mg mL-1 of ZnO@ZIF-8, 2 mg mL-1 of ZnO@ZIF-8 or sterile 
distilled water. Zero Galleria mellonella injected with 0.5 mg mL-1 of ZnO@ZIF-8, 2 mg mL 
ZnO@ZIF-8 or sterile distilled water had died by 72 h, whilst survival dropped to 90% after 48 h 
for the Galleria mellonella injected with 1 mg mL-1 ZnO@ZIF-8. Survival had decreased across 
all conditions by 96 hours, to a minimum of 70% survival (2 mg mL-1 ZnO@ZIF-8). These 
decreases in survival were considered not significant (P=0.5456) when comparing the survival 
data using a log-rank (mantel-cox) test, and therefore suggesting the ZnO@ZIF-8 compound was 
no more toxic to the Galleria mellonella at any of the tested concentrations when compared to 
distilled water. 
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Figure 5. Survival of Galleria mellonella after injection with 10 µL of 2 mg mL-1, 1 mg mL-1, 
0.5 mg mL-1 or 0.25 mg mL-1 of ZnO@ZIF-8 powder suspended in sterile distilled water. 10 µL 
of sterile distilled water was used as a control.  
Efficacy of ZnO@ZIF-8 as an antibiofilm agent. ZnO@ZIF-8 reduced the number of viable 
cells in all bacterial biofilms to below the level of detection (BLD - a six to eight log decrease 
compared to exposure to control solution), over a 24-h period, at the highest tested concentration 
of 2 mg mL-1 (Fig. 6). Reduction to BLD was demonstrated at all three tested concentrations of 
ZnO@ZIF-8 after 3 h for P. mirabilis (six-log reduction) and S. aureus (seven-log reduction). 
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Figure 6. Number of colony forming units (living bacteria) recovered from each biofilm after 
treatment with ZnO@ZIF-8 powder suspended in sterile distilled water. Microorganisms tested 
were a) E. coli, b) P. mirabilis, c) S. aureus and d) K. pneumoniae. 
For E. coli, the effect was concertation dependent, with 2 mg mL-1 ZnO@ZIF-8 reducing cell 
numbers BLD (eight-log drop) after three hours. 1 mg mL-1 ZnO@ZIF-8 reduced numbers by 
four-log within 3 h, and BLD by 8 h. 0.5 mg mL-1 was unable to reduce the biofilm below one-
log within the 24 h test period. Whilst K. pneumoniae biofilms treated with 0.5 mg mL-1 and 1 
mg mL-1 were not reduced BLD, they were able to provide a one and two-log decrease 
respectively. All colony forming unit counts were statistically significantly different (p<0.001 
except 8 h - 1 mg mL-1 sample for K. pneumoniae which was significant to p<0.05) compared to 
the matched control biofilm, using a 2-way ANOVA statistical test. 
The speed at which these biofilms and inocula on silicone are inactivated is of particular 
interest particularly when considering P. mirabilis. If left undisturbed in a catheter, this 
microorganism can produce urease, which increases the pH of the environment, leading to 
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crystalline deposits of calcium and magnesium phosphates, which can form encrustations and 
block the catheter. P. mirabilis has been shown to attach to catheter material within one hour, 
and produce diffuse crystalline deposits within four days.46 If ZnO@ZIF-8 is able to stop or 
retard growth on silicone material, the effect on subsequent CAUTIs could be significant. 
K. pneumoniae biofilms were the most resistant to ZnO@ZIF-8. Whilst these results are 
positive, they support the general observations that many Klebsiella species are known to 
produce a significant amount of biofilm matrix material, which enhances resistance to 
antimicrobial products and makes the removal of biofilm difficult. The strain of K. pneumoniae 
used in this study readily produces EPS, as can be seen in Fig. 7. Additionally, K. pneumoniae 
has been shown to produce more EPS when growing as a biofilm on silicone opposed to growing 
on other surfaces,47 and thus further characterization of the antimicrobial effect of ZnO@ZIF-8 
on such biofilms on catheter materials would be desirable. 
 
Figure 7. Scanning electron micrograph of K. pneumoniae in grown in biofilm on a silicone 
surface. Rod shaped cells are visible and embedded within the EPS produced by the cells. 
3.3.  Assessment of antimicrobial efficacy of ZnO@ZIF-8-containing silicone elastomers. 
ZnO@ZIF-8 embedded in silicone demonstrated antimicrobial properties against all four test 
organisms. M511 maxillofacial SE embedded with 2 wt.%  ZnO@ZIF-8 reduced S. aureus BLD 
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(five log decrease) within 3 h and reduced E. coli BLD by 8 h (five log decrease – silicone 
figure). Both P. mirabilis and K. pneumoniae were reduced BLD within 24 h (six log decrease), 
when inoculated onto SE containing 4 wt.%  (Fig. 8). 
 
Figure 8. Number of colony forming units (living bacteria) recovered from silicone coupons 
embedded with either 2 or 4 wt. % ZnO@ZIF-8 powder. Microorganisms tested were a) E. coli, 
b) P. mirabilis, c) S. aureus and d) K. pneumoniae. 
However, if cells are unable to survive on a catheter surface, then the likelihood of biofilm 
formation is reduced. Although neither K. pneumoniae or P. mirabilis were eliminated from the 
surface until 24 h, an effect was achieved. Both of these microorganisms were resistant overall to 
the treatment of ZnO@ZIF-8 compared to E. coli and S. aureus, demonstrating variability of 
susceptibility between microorganisms.  
4. CONCLUSIONS 
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We have successfully optimized the synthesis procedure for the preparation of gram-scale 
phase pure ZnO@ZIF-8 composite. As a proof of concept,  this study demonstrates the potential 
of ZnO@ZIF-8 composite as an antimicrobial additive to medical silicone devices such as 
catheters due to its ability to kill bacterial cells present on the surface of the silicone, as well as 
its promising anti-biofilm effect. This work also broadens the scope of MOF composite 
applications for widely applicable antimicrobial catheters. The results reported in this work, 
namely the ability of ZnO@ZIF-8 suspensions to reduce well-established microbial biofilms to 
beyond detection limit as well as the ability of ZnO@ZIF-8-embedded silicones to eliminate 
microorganisms from their surfaces, are significant for the quest to reduce catheter-associated 
urinary tract infections. Further work is in progress to investigate the ability of ZnO@ZIF-8-
embedded silicones to inhibit biofilm growth as well as to establish the mechanism of 
antimicrobial action. 
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